Cargando…

A novel prediction score for predicting the baseline risk of recurrence of stage I–II endometrial carcinoma

OBJECTIVE: To develop and validate a 3-year recurrence prediction score (RPS) system for predicting the baseline risk of recurrence of stage I–II endometrial carcinoma. METHODS: We reviewed 427 patients with International Federation of Gynecology and Obstetrics staging I–II endometrial carcinoma und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Kenta, Yunokawa, Mayu, Sasada, Shinsuke, Takehara, Yae, Miyasaka, Naoyuki, Kato, Tomoyasu, Tamura, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304400/ https://www.ncbi.nlm.nih.gov/pubmed/30479092 http://dx.doi.org/10.3802/jgo.2019.30.e8

Ejemplares similares

Baseline risk of recurrence in stage I–II endometrial carcinoma
por: Sasada, Shinsuke, et al.
Publicado: (2018)

Hotspot mutation profiles of AKT1 in Asian women with breast and endometrial cancers
por: Shimoi, Tatsunori, et al.
Publicado: (2021)

A phase I study of combined trabectedin and pegylated liposomal doxorubicin therapy for advanced relapsed ovarian cancer
por: Takahashi, Shunji, et al.
Publicado: (2021)

Prolonged Hypocalcemia Following a Single Dose of Denosumab for Diffuse Bone Metastasis of Gastric Cancer after Total Gastrectomy
por: Iizumi, Sakura, et al.
Publicado: (2017)

Oncologic Outcomes of Laparoscopic Radical Hysterectomy Using the No-Look No-Touch Technique for Early Stage Cervical Cancer: A Propensity Score-Adjusted Analysis
por: Fusegi, Atsushi, et al.
Publicado: (2021)

The baseline recurrence risk of patients with intermediate-risk cervical cancer
por: Yoneoka, Yutaka, et al.
Publicado: (2021)

Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors
por: Sestak, Ivana, et al.
Publicado: (2016)

Factors predicting recurrent endometrial cancer
por: Huijgens, A.N.J., et al.
Publicado: (2013)

Efficacy of intra-abdominal cytoreductive surgery in advanced endometrial cancer with distant metastasis
por: Kanno, Motoko, et al.
Publicado: (2023)

An integrated prediction model of recurrence in endometrial endometrioid cancers
por: Miller, Marina D, et al.
Publicado: (2019)

Diagnostic Accuracy of Hysteroscopic Scoring System in Predicting Endometrial Malignancy and Atypical Endometrial Hyperplasia
por: Harika, Bhukya, et al.
Publicado: (2021)

Content Analysis of Oncology-Related Pharmaceutical Advertising in a Peer-Reviewed Medical Journal
por: Yonemori, Kan, et al.
Publicado: (2012)

Lenvatinib plus pembrolizumab in Japanese patients with endometrial cancer: Results from Study 309/KEYNOTE‐775
por: Yonemori, Kan, et al.
Publicado: (2022)

Outcomes of salvage high-dose-rate brachytherapy with or without external beam radiotherapy for isolated vaginal recurrence of endometrial cancer
por: Sekii, Shuhei, et al.
Publicado: (2017)

Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer
por: Asami, Yuka, et al.
Publicado: (2022)

Baseline Urinary Angiotensinogen Excretion Predicts Deterioration of the Kidney Function in Patients with Chronic Kidney Disease
por: Ishigaki, Sayaka, et al.
Publicado: (2021)

A Nomogram Model for Predicting Recurrence of Stage I–III Endometrial Cancer Based on Inflammation-Immunity-Nutrition Score (IINS) and Traditional Classical Predictors
por: Jiang, Peng, et al.
Publicado: (2022)

Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients
por: Fukuda, Naoki, et al.
Publicado: (2020)

Brain Metastases from Uterine Cervical and Endometrial Cancer
por: Kato, Mayumi Kobayashi, et al.
Publicado: (2021)

Clinical Score to Predict Recurrence in Patients with Stage II and Stage III Colon Cancer
por: Viñal, David, et al.
Publicado: (2022)

A Nomogram Model Involving Immunohistochemical Markers for Predicting the Recurrence of Stage I-II Endometrial Cancer
por: Jiang, Peng, et al.
Publicado: (2021)

The application of machine learning for predicting recurrence in patients with early-stage endometrial cancer: a pilot study
por: Akazawa, Munetoshi, et al.
Publicado: (2021)

Malignant prediction of incidental findings using ring-type dedicated breast positron emission tomography
por: Sasada, Shinsuke, et al.
Publicado: (2022)

Recurrence of Overdose Suicide Attempt index: a novel scoring system for predicting the recurrence of intentional overdose
por: Hirose, Masayuki, et al.
Publicado: (2022)

Primary Yolk Sac Tumor of the Omentum: A Case Report and Literature Review
por: Harano, Kenichi, et al.
Publicado: (2012)

Pathological features of triple‐negative breast cancers that showed progressive disease during neoadjuvant chemotherapy
por: Tanabe, Yuko, et al.
Publicado: (2017)

Phase I study of taselisib in Japanese patients with advanced solid tumors or hormone receptor‐positive advanced breast cancer
por: Tamura, Kenji, et al.
Publicado: (2018)

Baseline factors predicting the need for corneal crosslinking in patients with keratoconus
por: Kato, Naoko, et al.
Publicado: (2020)

Dual-phase FDG PET/CT for predicting prognosis in operable breast cancer
por: Ikejiri, Haruka, et al.
Publicado: (2022)

Prediction of Recurrence by Preoperative Intratumoral FDG Uptake Heterogeneity in Endometrioid Endometrial Cancer
por: Kang, Seo Young, et al.
Publicado: (2017)

Integration of Genomic and Clinical Retrospective Data to Predict Endometrioid Endometrial Cancer Recurrence
por: Gonzalez-Bosquet, Jesus, et al.
Publicado: (2022)

Predicting the Risk of Recurrent Adenoma and Incident Colorectal Cancer Based on Findings of the Baseline Colonoscopy
por: Fairley, Kimberly J, et al.
Publicado: (2014)

A Risk-Scoring Model for the Prediction of Endometrial Cancer among Symptomatic Postmenopausal Women with Endometrial Thickness > 4 mm
por: Giannella, Luca, et al.
Publicado: (2014)

Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy
por: Ikeda, Yuji, et al.
Publicado: (2015)

Predicting tumor recurrence on baseline MR imaging in patients with early-stage hepatocellular carcinoma using deep machine learning
por: Kucukkaya, Ahmet Said, et al.
Publicado: (2023)

Alteration in molecular properties during establishment and passaging of endometrial carcinoma patient-derived xenografts
por: Imai, Toshio, et al.
Publicado: (2023)

Loss of ARID1A Expression as a Favorable Prognostic Factor in Early-Stage Grade 3 Endometrioid Endometrial Carcinoma Patients
por: Kato, Mayumi Kobayashi, et al.
Publicado: (2021)

Port site recurrence and unusual diffuse subcutaneous metastases of unexpected early stage ovarian cancer after laparoscopic surgery: a case report
por: Fusegi, Atsushi, et al.
Publicado: (2019)

Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer
por: Kanno, Motoko, et al.
Publicado: (2022)

Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis
por: Takeuchi, Tsutomu, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_g5eqb0nf89npmc1gr7jk3fnfmd